Literature DB >> 1570514

Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1.

D I Cohen1, Y Tani, H Tian, E Boone, L E Samelson, H C Lane.   

Abstract

Protein tyrosine phosphorylation is a common mechanism of signaling in pathways that regulate T cell receptor-mediated cell activation, cell proliferation, and the cell cycle. Because human immunodeficiency virus (HIV) is though to affect normal cell signaling, tyrosine phosphorylation may be associated with HIV cytopathicity. In both HIV-infected cells and transfected cells that stably express HIV envelope glycoproteins undergoing HIVgp41-induced cell fusion, a 30-kilodalton protein was phosphorylated on tyrosine with kinetics similar to those of syncytium formation and cell death. When tyrosine phosphorylation was inhibited by the protein tyrosine kinase inhibitor herbimycin A, envelope-mediated syncytium formation was coordinately reduced. These studies show that specific intracellular signals, which apparently participate in cytopathicity, are generated by HIV and suggest strategies by which the fusion process might be interrupted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570514     DOI: 10.1126/science.1570514

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.

Authors:  K Conant; M Ma; A Nath; E O Major
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

2.  Pentosan polysulfate, a potent anti HIV and anti tumor agent, inhibits protein serine/threonine and tyrosine kinases.

Authors:  A K Srivastava; R P Sékaly; J L Chiasson
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

3.  Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.

Authors:  Y Murakami; H Fukazawa; S Mizuno; Y Uehara
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

4.  Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants.

Authors:  W L Marshall; E S Mittler; P Avery; J P Lawrence; R W Finberg
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Inhibitory effect of tyrphostin on the replication of herpes simplex virus type 1.

Authors:  Y Yura; J Kusaka; Y Kondo; H Tsujimoto; H Yoshida; M Sato
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 6.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

7.  Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck.

Authors:  K Tokunaga; E Kiyokawa; M Nakaya; N Otsuka; A Kojima; T Kurata; M Matsuda
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase.

Authors:  Y Yura; H Yoshida; M Sato
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.

Authors:  V Kolesnitchenko; L M Wahl; H Tian; I Sunila; Y Tani; D P Hartmann; J Cossman; M Raffeld; J Orenstein; L E Samelson; D I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.